Share chart Peak Bio, Inc.
Extended chart
Simple chart
About Peak Bio, Inc.
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with inflammatory, cancer, and rare and specialty diseases. Its lead product candidate is PHP-303, which is in phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate for solid tumors. The company was founded in 2020 and is headquartered in Palo Alto, California.| IPO date | 2021-03-15 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://peak-bio.com |
| Цена ао | 0.0225 |
| Change price per day: | 0% (0.0225) |
|---|---|
| Change price per week: | 0% (0.0225) |
| Change price per month: | 0% (0.0225) |
| Change price per 3 month: | 0% (0.0225) |
| Change price per half year: | 0% (0.0225) |
| Change price per year: | +150% (0.009) |
| Change price per year to date: | 0% (0.0225) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Palo Alto Investors Lp | 497528 | 2.33 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Hoyoung Huh M.D., Ph.D. | Executive Chairman | 1.67M | 1969 (56 years) |
| Dr. Satyajit Mitra Ph.D. | Head of Oncology & Executive Director | 317.22k | 1975 (50 years) |
| Ms. Moddy Wong | Director of Human Resources | N/A | |
| Ms. Divya Patel | Controller & Treasurer | N/A |
Address: United States, Pleasanton. CA, 4900 Hopyard Road - open in Google maps, open in Yandex maps
Website: https://peak-bio.com
Website: https://peak-bio.com
